These results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 aid the strategy of focusing on ACKR3 as a singular method to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Ailme